Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sucralose dental carries claim

This article was originally published in The Tan Sheet

Executive Summary

McNeil Nutritionals petition seeks noncariogenicity dental health claim: "Frequent eating of foods high in sugars and starches as between-meal snacks can promote tooth decay. Sucralose, the sweetening ingredient used to sweeten this food, unlike sugars, may reduce the risk of dental caries." Studies consistently have shown that "sucralose neither supports the growth of oral bacteria nor allows such bacteria to lower oral pH below 5.7," the firm states. No sub-populations are at risk of sucralose in its intended uses, and none require special considerations, according to the marketer of sucralose-containing Splenda No-Calorie Sweetener...

McNeil Nutritionals petition seeks noncariogenicity dental health claim: "Frequent eating of foods high in sugars and starches as between-meal snacks can promote tooth decay. Sucralose, the sweetening ingredient used to sweeten this food, unlike sugars, may reduce the risk of dental caries." Studies consistently have shown that "sucralose neither supports the growth of oral bacteria nor allows such bacteria to lower oral pH below 5.7," the firm states. No sub-populations are at risk of sucralose in its intended uses, and none require special considerations, according to the marketer of sucralose-containing Splenda No-Calorie Sweetener....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097127

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel